Once the brain is injured, GPL metabolism is significantly altered, thus becoming an indicative characteristic of many brain diseases, such as traumatic brain injury (TBI) [61], Alzheimer’s disease (AD) [62,63], and post-stroke depression (PSD) [64]. This evidence concerns the gene IL31RA and Alzheimer disease.